A review of chronic granulomatous disease

DE Arnold, JR Heimall - Advances in therapy, 2017 - Springer
Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by defects in
any of the five subunits of the NADPH oxidase complex responsible for the respiratory burst …

From flies to men: ROS and the NADPH oxidase in phagocytes

ZM Moghadam, P Henneke, J Kolter - Frontiers in cell and …, 2021 - frontiersin.org
The cellular formation of reactive oxygen species (ROS) represents an evolutionary ancient
antimicrobial defense system against microorganisms. The NADPH oxidases (NOX), which …

Tuberculosis in otherwise healthy adults with inherited TNF deficiency

AA Arias, AL Neehus, M Ogishi, V Meynier, A Krebs… - Nature, 2024 - nature.com
Severe defects in human IFNγ immunity predispose individuals to both Bacillus Calmette–
Guérin disease and tuberculosis, whereas milder defects predispose only to tuberculosis …

Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives

L Abel, J Fellay, DW Haas, E Schurr… - The Lancet infectious …, 2018 - thelancet.com
Tuberculosis is an ancient human disease, estimated to have originated and evolved over
thousands of years alongside modern human populations. Despite considerable advances …

Inherited p40phox deficiency differs from classic chronic granulomatous disease

A Van De Geer, A Nieto-Patlán, DB Kuhns… - The Journal of clinical …, 2018 - jci.org
Biallelic loss-of-function (LOF) mutations of the NCF4 gene, encoding the p40 phox subunit
of the phagocyte NADPH oxidase, have been described in only 1 patient. We report on 24 …

BCG: a vaccine with multiple faces

MA Yamazaki-Nakashimada, A Unzueta… - Human vaccines & …, 2020 - Taylor & Francis
ABSTRACT BCG has been recommended because of its efficacy against disseminated and
meningeal tuberculosis. The BCG vaccine has other mechanisms of action besides …

Fourth update on the Iranian National Registry of Primary Immunodeficiencies: integration of molecular diagnosis

H Abolhassani, F Kiaee, M Tavakol… - Journal of clinical …, 2018 - Springer
Background The number of inherited diseases and the spectrum of clinical manifestations of
primary immunodeficiency disorders (PIDs) are ever-expanding. Molecular diagnosis using …

Primary immunodeficiency diseases and Bacillus Calmette-Guérin (BCG)-vaccine–derived complications: a systematic review

S Fekrvand, R Yazdani, P Olbrich, A Gennery… - The Journal of Allergy …, 2020 - Elsevier
Background Bacillus Calmette-Guérin (BCG) vaccine is a live attenuated bacterial vaccine
derived from Mycobacterium bovis, which is mostly administered to neonates in regions …

A BCG kill switch strain protects against Mycobacterium tuberculosis in mice and non-human primates with improved safety and immunogenicity

AA Smith, H Su, J Wallach, Y Liu, P Maiello… - Nature …, 2025 - nature.com
Improved vaccination strategies for tuberculosis are needed. Intravenous (iv) delivery of live
attenuated Mycobacterium bovis BCG provides protection against Mycobacterium …

Life-threatening infections due to live-attenuated vaccines: early manifestations of inborn errors of immunity

L Pöyhönen, J Bustamante, JL Casanova… - Journal of clinical …, 2019 - Springer
Live-attenuated vaccines (LAVs) can protect humans against 12 viral and three bacterial
diseases. By definition, any clinical infection caused by a LAV that is sufficiently severe to …